亚洲AV成人片色在线观看高潮_亚洲精品成a人在线观看夫_日本久久久久久久久精品_亚洲精品无码成人在线观看

糖抗原125(CA125)重組蛋白

Recombinant Carbohydrate Antigen 125 (CA125)

MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125

  • 糖抗原125(CA125)重組蛋白 產(chǎn)品包裝(模擬)
  • 糖抗原125(CA125)重組蛋白 產(chǎn)品包裝(模擬)
  • RPA154Hu02.jpg Figure. SDS-PAGE
  • Certificate 通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

序列

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào) 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPA154Hu01 糖抗原125(CA125)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA154Hu02 糖抗原125(CA125)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA154Hu01 糖抗原125(CA125)多克隆抗體 WB; IHC; ICC; IP.
PAA154Hu02 糖抗原125(CA125)多克隆抗體 WB; IHC; ICC; IP.
LAA154Hu81 糖抗原125(CA125)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
LAA154Hu71 糖抗原125(CA125)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
MAA154Hu22 糖抗原125(CA125)單克隆抗體 WB; IHC; ICC; IP.
SEA154Hu 糖抗原125(CA125)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA154Hu 糖抗原125(CA125)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
KSA154Hu01 糖抗原125(CA125)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志 參考文獻(xiàn)
PLoS One Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice. [pubmed:27755542]
Tumor Biology KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis [pubmed:28651492]
Oncotarget Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer [Pubmed:29484129]
Prognostic value of STC1 expression in ovarian cancer []
American Journal of Translational Research Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway [Pubmed:35422913]
留言咨詢